Healthpeak Properties (NYSE:DOC) Coverage Initiated at Barclays

Research analysts at Barclays began coverage on shares of Healthpeak Properties (NYSE:DOC) in a note issued to investors on Tuesday,Benzinga reports. The firm set an “equal weight” rating and a $23.00 price target on the real estate investment trust’s stock. Barclays‘s price target points to a potential upside of 5.75% from the company’s current price.

DOC has been the subject of several other research reports. Raymond James Financial assumed coverage on shares of Healthpeak Properties in a research report on Wednesday, June 17th. They issued a “market perform” rating for the company. JPMorgan Chase & Co. upped their price target on shares of Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Mizuho increased their price target on Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a report on Monday. Citigroup raised their price objective on Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research report on Tuesday, May 12th. Finally, UBS Group boosted their price objective on Healthpeak Properties from $17.00 to $19.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 13th. Four research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $20.35.

Healthpeak Properties Stock Down 0.6%

Shares of NYSE:DOC opened at $21.75 on Tuesday. The stock has a 50-day simple moving average of $19.65 and a 200-day simple moving average of $17.89. The stock has a market capitalization of $14.99 billion, a P/E ratio of 67.97, a PEG ratio of 3.41 and a beta of 1.02. Healthpeak Properties has a 1 year low of $15.70 and a 1 year high of $22.04. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, beating the consensus estimate of $0.43 by $0.02. The firm had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. Healthpeak Properties’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Equities analysts forecast that Healthpeak Properties will post 1.75 earnings per share for the current year.

Insider Activity at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the transaction, the insider directly owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.23% of the company’s stock.

Institutional Investors Weigh In On Healthpeak Properties

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Integrated Wealth Concepts LLC lifted its stake in shares of Healthpeak Properties by 7.3% in the first quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock worth $366,000 after acquiring an additional 1,231 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Healthpeak Properties by 110.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock valued at $2,463,000 after buying an additional 63,930 shares during the last quarter. Woodline Partners LP raised its position in shares of Healthpeak Properties by 41.3% during the 1st quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock worth $1,195,000 after purchasing an additional 17,279 shares during the period. Brown Advisory Inc. increased its position in Healthpeak Properties by 3.1% in the second quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock worth $819,000 after buying an additional 1,415 shares during the period. Finally, Qube Research & Technologies Ltd bought a new stake in Healthpeak Properties in the second quarter valued at $3,117,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.